6.
Pan E, Feng F, Li P, Yang Q, Ma X, Wu C
. Immune Protection of SIV Challenge by PD-1 Blockade During Vaccination in Rhesus Monkeys. Front Immunol. 2018; 9:2415.
PMC: 6206945.
DOI: 10.3389/fimmu.2018.02415.
View
7.
Lopez Bernal J, Andrews N, Gower C, Robertson C, Stowe J, Tessier E
. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021; 373:n1088.
PMC: 8116636.
DOI: 10.1136/bmj.n1088.
View
8.
Romero Starke K, Reissig D, Petereit-Haack G, Schmauder S, Nienhaus A, Seidler A
. The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis. BMJ Glob Health. 2021; 6(12).
PMC: 8678541.
DOI: 10.1136/bmjgh-2021-006434.
View
9.
Feng S, Phillips D, White T, Sayal H, Aley P, Bibi S
. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med. 2021; 27(11):2032-2040.
PMC: 8604724.
DOI: 10.1038/s41591-021-01540-1.
View
10.
Wagner A, Garner-Spitzer E, Jasinska J, Kollaritsch H, Stiasny K, Kundi M
. Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules. Sci Rep. 2018; 8(1):9825.
PMC: 6026142.
DOI: 10.1038/s41598-018-28111-8.
View
11.
Franceschi C, Campisi J
. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014; 69 Suppl 1:S4-9.
DOI: 10.1093/gerona/glu057.
View
12.
Collier D, Ferreira I, Kotagiri P, Datir R, Lim E, Touizer E
. Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature. 2021; 596(7872):417-422.
PMC: 8373615.
DOI: 10.1038/s41586-021-03739-1.
View
13.
Harris R, Hall J, Zaidi A, Andrews N, Dunbar J, Dabrera G
. Effect of Vaccination on Household Transmission of SARS-CoV-2 in England. N Engl J Med. 2021; 385(8):759-760.
PMC: 8262621.
DOI: 10.1056/NEJMc2107717.
View
14.
Ewer K, Barrett J, Belij-Rammerstorfer S, Sharpe H, Makinson R, Morter R
. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat Med. 2020; 27(2):270-278.
DOI: 10.1038/s41591-020-01194-5.
View
15.
Kurachi M, Kurachi J, Suenaga F, Tsukui T, Abe J, Ueha S
. Chemokine receptor CXCR3 facilitates CD8(+) T cell differentiation into short-lived effector cells leading to memory degeneration. J Exp Med. 2011; 208(8):1605-20.
PMC: 3149224.
DOI: 10.1084/jem.20102101.
View
16.
Liu J, Yu J, McMahan K, Jacob-Dolan C, He X, Giffin V
. CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques. Sci Immunol. 2022; 7(77):eabq7647.
PMC: 9407944.
DOI: 10.1126/sciimmunol.abq7647.
View
17.
Rudd B, Venturi V, Li G, Samadder P, Ertelt J, Way S
. Nonrandom attrition of the naive CD8+ T-cell pool with aging governed by T-cell receptor:pMHC interactions. Proc Natl Acad Sci U S A. 2011; 108(33):13694-9.
PMC: 3158207.
DOI: 10.1073/pnas.1107594108.
View
18.
Kingstad-Bakke B, Lee W, Chandrasekar S, Gasper D, Salas-Quinchucua C, Cleven T
. Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants. Proc Natl Acad Sci U S A. 2022; 119(20):e2118312119.
PMC: 9171754.
DOI: 10.1073/pnas.2118312119.
View
19.
Quinn K, Fox A, Harland K, Russ B, Li J, Nguyen T
. Age-Related Decline in Primary CD8 T Cell Responses Is Associated with the Development of Senescence in Virtual Memory CD8 T Cells. Cell Rep. 2018; 23(12):3512-3524.
DOI: 10.1016/j.celrep.2018.05.057.
View
20.
Zhang H, Weyand C, Goronzy J
. Hallmarks of the aging T-cell system. FEBS J. 2021; 288(24):7123-7142.
PMC: 8364928.
DOI: 10.1111/febs.15770.
View